52 related articles for article (PubMed ID: 24605912)
1. YAP1 expression in myelodysplastic syndromes and acute leukemias.
Machado-Neto JA; de Melo Campos P; Olalla Saad ST; Traina F
Leuk Lymphoma; 2014 Oct; 55(10):2413-5. PubMed ID: 24605912
[No Abstract] [Full Text] [Related]
2. MST1/2 and YAP1 gene expression in acute myeloid leukemia.
Safari S; Movafagh A; Zare-Adollahi D; Ghadiani M; Riazi-Isfahani S; Safavi-Naini N; Omrani MD
Leuk Lymphoma; 2014 Sep; 55(9):2189-91. PubMed ID: 24303784
[No Abstract] [Full Text] [Related]
3. Elevated PIM2 gene expression is associated with poor survival of patients with acute myeloid leukemia.
Kapelko-Slowik K; Owczarek TB; Grzymajlo K; Urbaniak-Kujda D; Jazwiec B; Slowik M; Kuliczkowski K; Ugorski M
Leuk Lymphoma; 2016 Sep; 57(9):2140-9. PubMed ID: 26764044
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapies: Hippo effector YAP1 inhibition—towards a new therapeutic option to overcome drug resistance.
Errico A
Nat Rev Clin Oncol; 2015 Apr; 12(4):190. PubMed ID: 25707626
[No Abstract] [Full Text] [Related]
5. RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver.
Yin H; Bogorad RL; Barnes C; Walsh S; Zhuang I; Nonaka H; Ruda V; Kuchimanchi S; Nechev L; Akinc A; Xue W; Zerial M; Langer R; Anderson DG; Koteliansky V
J Hepatol; 2016 Apr; 64(4):899-907. PubMed ID: 26658687
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of DOK2 tumor suppressor gene in acute leukemias.
Kim MS; Chung NG; Yoo NJ; Lee SH
Leuk Res; 2011 Jun; 35(6):e87-8. PubMed ID: 21329978
[No Abstract] [Full Text] [Related]
7. YAP in MAPK pathway targeted therapy resistance.
Flaherty KT; Wargo JA; Bivona TG
Cell Cycle; 2015; 14(12):1765-6. PubMed ID: 26036142
[No Abstract] [Full Text] [Related]
8. An alternative DNA damage pathway to apoptosis in hematological cancers.
Luk JM; Guan KL
Nat Med; 2014 Jun; 20(6):587-8. PubMed ID: 24901566
[No Abstract] [Full Text] [Related]
9. Bone marrow cells of myelodysplastic syndromes exhibit significant expression of apollon, livin and ILP-2 with reduction after transformation to overt leukemia.
Abe S; Yamamoto K; Hasegawa M; Inoue M; Kurata M; Hirokawa K; Kitagawa M; Nakagawa Y; Suzuki K
Leuk Res; 2005 Sep; 29(9):1095-6. PubMed ID: 16038738
[No Abstract] [Full Text] [Related]
10. KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.
Moleirinho S; Chang N; Sims AH; Tilston-Lünel AM; Angus L; Steele A; Boswell V; Barnett SC; Ormandy C; Faratian D; Gunn-Moore FJ; Reynolds PA
Oncogene; 2013 Apr; 32(14):1821-30. PubMed ID: 22614006
[TBL] [Abstract][Full Text] [Related]
11. Novel human oncogene lbc detected by transfection with distinct homology regions to signal transduction products.
Toksoz D; Williams DA
Oncogene; 1994 Feb; 9(2):621-8. PubMed ID: 8290273
[TBL] [Abstract][Full Text] [Related]
12. Prospective long-term minimal residual disease monitoring using RQ-PCR in RUNX1-RUNX1T1-positive acute myeloid leukemia: results of the French CBF-2006 trial.
Willekens C; Blanchet O; Renneville A; Cornillet-Lefebvre P; Pautas C; Guieze R; Ifrah N; Dombret H; Jourdan E; Preudhomme C; Boissel N;
Haematologica; 2016 Mar; 101(3):328-35. PubMed ID: 26635039
[TBL] [Abstract][Full Text] [Related]
13. [Expression and Significance of Pim-3 Gene in Acute Myeloid Leukemia].
Zhou ZC; Tian ZG; Yuan Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Apr; 24(2):316-20. PubMed ID: 27150984
[TBL] [Abstract][Full Text] [Related]
14. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia.
Yasuda T; Shirakata M; Iwama A; Ishii A; Ebihara Y; Osawa M; Honda K; Shinohara H; Sudo K; Tsuji K; Nakauchi H; Iwakura Y; Hirai H; Oda H; Yamamoto T; Yamanashi Y
J Exp Med; 2004 Dec; 200(12):1681-7. PubMed ID: 15611294
[TBL] [Abstract][Full Text] [Related]
15. Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.
Jamalpour M; Li X; Cavelier L; Gustafsson K; Mostoslavsky G; Höglund M; Welsh M
Tumour Biol; 2017 Oct; 39(10):1010428317720643. PubMed ID: 28982308
[TBL] [Abstract][Full Text] [Related]
16. The DeMSTification of mammalian Ste20 kinases.
Radu M; Chernoff J
Curr Biol; 2009 May; 19(10):R421-5. PubMed ID: 19467213
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins.
Ong SH; Hadari YR; Gotoh N; Guy GR; Schlessinger J; Lax I
Proc Natl Acad Sci U S A; 2001 May; 98(11):6074-9. PubMed ID: 11353842
[TBL] [Abstract][Full Text] [Related]
18. The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.
Asano J; Nakano A; Oda A; Amou H; Hiasa M; Takeuchi K; Miki H; Nakamura S; Harada T; Fujii S; Kagawa K; Endo I; Yata K; Sakai A; Ozaki S; Matsumoto T; Abe M
Leukemia; 2011 Jul; 25(7):1182-8. PubMed ID: 21475253
[TBL] [Abstract][Full Text] [Related]
19. YAP1 oncogene and its eight isoforms.
Sudol M
Oncogene; 2013 Aug; 32(33):3922. PubMed ID: 23160371
[No Abstract] [Full Text] [Related]
20. Mutation of the human FMS gene (M-CSF receptor) in myelodysplastic syndromes and acute myeloid leukemia.
Tobal K; Pagliuca A; Bhatt B; Bailey N; Layton DM; Mufti GJ
Leukemia; 1990 Jul; 4(7):486-9. PubMed ID: 2142747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
